Education on Inhaler Technique by Pharmacists To Improve The Quality of Life of COPD Patients: A Systematic Review and Meta-Analysis
DOI:
https://doi.org/10.36497/jri.v43i4.479Keywords:
COPD, Hospital Pharmacist, Inhaler Technique EducationAbstract
Background: This systematic review aimed to analyze the importance of education on using inhalers by pharmacists in improving quality of life, correct inhaler use steps, and medication adherence in patients with Chronic Obstructive Pulmonary Disease (COPD).
Methods: The databases used to search for articles in this systematic review include Scopus, ScienceDirect, and Pubmed. The papers submitted were published between 2009 and 2022, with the most recent search being conducted in December 2022. This review included a randomized controlled trial evaluating education on inhaler use techniques by pharmacists to improve COPD patients' quality of life in inpatient and outpatient settings. This systematic review follows the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) writing guidelines.
Results: This systematic review used six articles from five different countries. The articles involved share similar characteristics so that analysis can be carried out. The total number of research subjects included was 913 subjects. Most studies show an increase in the quality of life among COPD patients who are given education on how to use inhalers by pharmacists using print or digital media. Measurements using the St. George's Respiratory Questionnaire (SGRQ) showed a decrease in scores at the 6-month and 12-month periods (-0.75 [95% CI (-1.46 - (-.005)]. Furthermore, two articles reported that education on the technique of using inhalers by pharmacists can also increase the accuracy of using inhalers, and three articles reported increasing medication adherence.
Conclusion: Interventions such as education on using inhalers by pharmacists in inpatient and outpatient settings can improve the quality of life of COPD patients, the accuracy of the steps in using inhalers, and medication adherence.
Downloads
References
Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (2023 report). 2023.
GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1204–22.
Safiri S, Carson-Chahhoud K, Noori M, Nejadghaderi SA, Sullman MJM, Ahmadian Heris J, et al. Burden of chronic obstructive pulmonary disease and its attributable risk factors in 204 countries and territories, 1990-2019: results from the Global Burden of Disease Study 2019. BMJ. 2022;378:e069679.
Zou J, Sun T, Song X, Liu YM, Lei F, Chen MM, et al. Distributions and trends of the global burden of COPD attributable to risk factors by SDI, age, and sex from 1990 to 2019: a systematic analysis of GBD 2019 data. Respir Res. 2022;23(1):90.
Wang C, Liu K, Sun X, Yin Y, Tang T. Effectiveness of motivational interviewing among patients with COPD: A systematic review with meta-analysis and trial sequential analysis of randomized controlled trials. Patient Educ Couns. 2022;105(11):3174–85.
World Health Organization. Chronic obstructive pulmonary disease (COPD) [Internet]. World Health Organization Eastern Mediterranean Region. [cited 2023 Feb 5]. Available from: https://www.emro.who.int/health-topics/chronic-obstructive-pulmonary-disease-copd/index.html
Bhattarai B, Walpola R, Khan S, Mey A. Factors associated with medication adherence among people living with COPD: Pharmacists’ perspectives. Exploratory Research in Clinical and Social Pharmacy. 2021;3:100049.
Monteiro C, Maricoto T, Prazeres F, Augusto Simões P, Augusto Simões J. Determining factors associated with inhaled therapy adherence on asthma and COPD: A systematic review and meta-analysis of the global literature. Respir Med. 2022;191:106724.
Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (2022 report). 2022.
Galal IH, Mohammad YM, Nada AA, Mohran YE. Medication adherence and treatment satisfaction in some Egyptian patients with chronic obstructive pulmonary disease and bronchial asthma. Egyptian Journal of Bronchology 2018 12:1. 2018;12(1):33–40.
Sanaullah T, Khan S, Masoom A, Mandokhail ZK, Sadiqa A, Malik MI. Inhaler use technique in chronic obstructive pulmonary disease patients: Errors, practices and barriers. Cureus. 2020;12(9):e10569.
Lindh A, Theander K, Arne M, Lisspers K, Lundh L, Sandelowsky H, et al. One additional educational session in inhaler use to patients with COPD in primary health care - A controlled clinical trial. Patient Educ Couns. 2022;105(9):2969–75.
Lin G, Zheng J, Tang PK, Zheng Y, Hu H, Ung COL. Effectiveness of hospital pharmacist interventions for COPD patients: A systematic literature review and logic model. Int J Chron Obstruct Pulmon Dis. 2022;17:2757–88.
Press VG, Arora VM, Shah LM, Lewis SL, Charbeneau J, Naureckas ET, et al. Teaching the use of respiratory inhalers to hospitalized patients with asthma or COPD: a randomized trial. J Gen Intern Med. 2012;27(10):1317–25.
Snoswell CL, Draper MJ, Barras M. An evaluation of pharmacist activity in hospital outpatient clinics. Journal of Pharmacy Practice and Research. 2021;51(4):328–32.
Cook DA, Reed DA. Appraising the quality of medical education research methods: the Medical Education Research Study Quality Instrument and the Newcastle-Ottawa Scale-Education. Acad Med. 2015;90(8):1067–76.
Reed DA, Cook DA, Beckman TJ, Levine RB, Kern DE, Wright SM. Association between funding and quality of published medical education research. JAMA. 2007;298(9):1002–9.
Khdour MR, Kidney JC, Smyth BM, McElnay JC. Clinical pharmacy-led disease and medicine management programme for patients with COPD. Br J Clin Pharmacol. 2009;68(4):588–98.
Jarab AS, AlQudah SG, Khdour M, Shamssain M, Mukattash TL. Impact of pharmaceutical care on health outcomes in patients with COPD. Int J Clin Pharm. 2012;34(1):53–62.
Suhaj A, Manu MK, Unnikrishnan MK, Vijayanarayana K, Mallikarjuna Rao C. Effectiveness of clinical pharmacist intervention on health-related quality of life in chronic obstructive pulmonary disorder patients - a randomized controlled study. J Clin Pharm Ther. 2016;41(1):78–83.
Xin C, Xia Z, Jiang C, Lin M, Li G. The impact of pharmacist-managed clinic on medication adherence and health-related quality of life in patients with COPD: a randomized controlled study. Patient Prefer Adherence. 2016;10:1197–203.
Wang W, Xu T, Qin Q, Miao L, Bao J, Chen R. Effect of a multidimensional pharmaceutical care intervention on inhalation technique in patients with asthma and COPD. Can Respir J. 2020;2020.
Kebede AT, Trapnes E, Lea M, Abrahamsen B, Mathiesen L. Effect of pharmacist-led inhaler technique assessment service on readmissions in hospitalized COPD patients: A randomized, controlled pilot study. BMC Pulm Med. 2022;22(1):1–11.
Jones PW, Brusselle G, Dal Negro RW, Ferrer M, Kardos P, Levy ML, et al. Properties of the COPD assessment test in a cross-sectional European study. Eur Respir J. 2011;38(1):29–35.
Ringbaek T, Martinez G, Lange P. A comparison of the assessment of quality of life with CAT, CCQ, and SGRQ in COPD patients participating in pulmonary rehabilitation. COPD. 2012;9(1):12–5.
Ying Y, Khunthason S, Nilvarangkul K. Factors associated with good quality of life among chronic objective pulmonary disease patients in Zhejiang province, China: A cross-sectional study. 2022;
Pandey AR, Chalise HN, Shrestha A, Ranjit A. Quality of life of patients with chronic obstructive pulmonary disease attending a tertiary care hospital, Kavre, Nepal. Kathmandu University Medical Journal. 2021;19(2):180–5.
Rogliani P, Ora J, Puxeddu E, Matera MG, Cazzola M. Adherence to COPD treatment: Myth and reality. Respir Med. 2017;129:117–23.
Nguyen TS, Nguyen TLH, Pham TT Van, Hua S, Ngo QC, Li SC. Impact of pharmaceutical care in the improvement of medication adherence and quality of life for COPD patients in Vietnam. Respir Med. 2019;153:31–7.
DePietro M, Gilbert I, Millette LA, Riebe M. Inhalation device options for the management of chronic obstructive pulmonary disease. Postgrad Med. 2018;130(1):83–97.
Global Initiative for Asthma. 2022 GINA Report, Global strategy for asthma management and prevention. 2022.
George M, Bender B. New insights to improve treatment adherence in asthma and COPD. Patient Prefer Adherence. 2019;13:1325–34.
Downloads
Additional Files
- Suplementary Table 1. Keyword Arrangement
- Supplementary Table 2. Kappa Score
- Supplementary Table 3. MERSQI Score
- Supplementary Table 4. Article Characteristics
- Revisi File Name Artikel
- UI_Sarah Almira_Publising Agreement
- turnitin checker
- Receipt Turnitin
- Naskah Turnitin Checker
- Turnitin Checker Text
- Revised Manuscript
- Response Letter
Published
Issue
Section
License
- The authors own the copyright of published articles. Nevertheless, Jurnal Respirologi Indonesia has the first-to-publish license for the publication material.
- Jurnal Respirologi Indonesia has the right to archive, change the format and republish published articles by presenting the authors’ names.
- Articles are published electronically for open access and online for educational, research, and archiving purposes. Jurnal Respirologi Indonesia is not responsible for any copyright issues that might emerge from using any article except for the previous three purposes.
